Time-to-event analyses further indicated delayed time to conception and live birth among semaglutide users, potentially reflecting follicular, endometrial, or endocrine perturbations
However, enzyme supplements may cause their own gastrointestinal side effects that can overlap with GLP-1-related symptoms, and some formulations containing bromelain or papain may interact with anticoagulants
Any treatment is provided only after a comprehensive evaluation by a licensed medical provider
GLP-1 is secreted in response to carbohydrate, fat, and protein ingestion
NEJM 2022 FDA Approves New Drug Treatment for Chronic Weight Management (Wegovy) FDA Approves New Medication for Chronic Weight Management (Zepbound) Frias JP et al
A lot of questions have not been answered. Dr